113 related articles for article (PubMed ID: 7823896)
1. [A ornithine decarboxylase activity and proliferating cell nuclear antigen in gastric cancer].
Hoshino Y; Teranishi Y; Terashima S; Ito F; Konno A; Inoue H; Motoki R
Nihon Geka Gakkai Zasshi; 1994 Oct; 95(10):743-52. PubMed ID: 7823896
[TBL] [Abstract][Full Text] [Related]
2. Significance of proliferating cell nuclear antigen (PCNA) expression in gastric cancer in relation to lymph node metastasis.
Isozaki H; Okajima K; Ichinona T; Fujii K; Nomura E; Izumi N; Takeda Y
J Surg Oncol; 1996 Feb; 61(2):106-10. PubMed ID: 8606541
[TBL] [Abstract][Full Text] [Related]
3. The expression of proliferating cell nuclear antigen (PCNA) and p 53 protein correlate with prognosis of patients with oral squamous cell carcinoma.
Kurokawa H; Yamashita Y; Takeda S; Miura K; Murata T; Kajiyama M
Fukuoka Igaku Zasshi; 1999 Jan; 90(1):6-13. PubMed ID: 10087668
[TBL] [Abstract][Full Text] [Related]
4. Increased mucosal ornithine decarboxylase activity in human gastric cancer.
Okuzumi J; Yamane T; Kitao Y; Tokiwa K; Yamaguchi T; Fujita Y; Nishino H; Iwashima A; Takahashi T
Cancer Res; 1991 Mar; 51(5):1448-51. PubMed ID: 1997184
[TBL] [Abstract][Full Text] [Related]
5. Expression of p53 protein in gastric cancer: an immunohistochemical study with correlation to proliferative activity.
Ioachim E; Goussia A; Stefanou D; Agnantis NJ
Anticancer Res; 1997; 17(1A):513-7. PubMed ID: 9066704
[TBL] [Abstract][Full Text] [Related]
6. [Significance of COX-2, p53, proliferating cell nuclear antigen and nm23 expressions in gastric cancer and its behavior].
Ji SQ; Hua YW; Zhuang J; Gao Y; Kong Y; Han SL; Shao YF
Ai Zheng; 2002 Jun; 21(6):619-24. PubMed ID: 12452062
[TBL] [Abstract][Full Text] [Related]
7. Serum carcinoembryonic antigen levels and proliferating cell nuclear antigen labeling index for patients with colorectal carcinoma. Correlation with tumor progression and survival.
Nakamura T; Tabuchi Y; Nakae S; Ohno M; Saitoh Y
Cancer; 1996 Apr; 77(8 Suppl):1741-6. PubMed ID: 8608572
[TBL] [Abstract][Full Text] [Related]
8. [mRNA expression of basic fibroblast growth factor and hepatocyte growth factor in gastric carcinoma and significance thereof].
Ru GQ; Zhao ZS; Tang QL; Xu WJ
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2030-5. PubMed ID: 19080429
[TBL] [Abstract][Full Text] [Related]
9. Relations of proliferative activities of gastric carcinoma cells to lymphatic involvement, venous invasion and prognosis.
Wu YF; Xu HM; Chen JQ
Chin Med J (Engl); 2004 Oct; 117(10):1530-5. PubMed ID: 15498378
[TBL] [Abstract][Full Text] [Related]
10. Topoisomerase I protein expression in primary colorectal cancer and lymph node metastases.
Boonsong A; Curran S; McKay JA; Cassidy J; Murray GI; McLeod HL
Hum Pathol; 2002 Nov; 33(11):1114-9. PubMed ID: 12454816
[TBL] [Abstract][Full Text] [Related]
11. The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors.
Chou YP; Lin JW; Wang CC; Chiu YC; Huang CC; Chuah SK; Tai MH; Yi LN; Lee CM; Changchien CS; Hu TH
Oncol Rep; 2008 Jan; 19(1):49-56. PubMed ID: 18097575
[TBL] [Abstract][Full Text] [Related]
12. [Assessment of proliferative cell nuclear antigen expression and clinical prognosis in gastric malignant lymphoma].
Tsurumachi T; Gunji S; Suzuki T; Nagata M; Nakajima K; Matsubara H; Koide Y; Ochiai T; Isono K
Gan To Kagaku Ryoho; 1996 Nov; 23(13):1781-5. PubMed ID: 8937488
[TBL] [Abstract][Full Text] [Related]
13. Histologic grade and cellular proliferation at the deepest invasive portion correlate with the high malignancy of submucosal invasive gastric carcinoma.
Nishida T; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G
Oncology; 1995; 52(4):340-6. PubMed ID: 7777250
[TBL] [Abstract][Full Text] [Related]
14. Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection.
Hanaoka N; Tanabe S; Mikami T; Okayasu I; Saigenji K
Endoscopy; 2009 May; 41(5):427-32. PubMed ID: 19418397
[TBL] [Abstract][Full Text] [Related]
15. Relationship between immunohistochemical evaluation of thymidylate synthase and proliferating cell nuclear antigen labeling index in gastrointestinal carcinoma.
Kunimoto Y; Nakamura T; Ohno M; Kuroda Y
Oncol Rep; 2004 Dec; 12(6):1163-7. PubMed ID: 15547732
[TBL] [Abstract][Full Text] [Related]
16. Relationships among the expression of epidermal growth factor receptor, proliferating cell nuclear antigen labeling index, and lymph node metastasis in gastric cancer.
Iida A; Hirose K; Arai M; Yamaguchi A; Nakagawara G
Oncology; 1995; 52(3):189-95. PubMed ID: 7715902
[TBL] [Abstract][Full Text] [Related]
17. [The ornithine decarboxylase activity of the gastric remnant mucosa: the effect of the duodenal juice with bile on the gastric mucosa].
Murakami S; Haruma K; Sumii K; Tari A; Yoshihara M; Kajiyama G; Takezaki E; Kagawa K; Omori H
Gan No Rinsho; 1990 Mar; 36(4):485-7. PubMed ID: 2319691
[TBL] [Abstract][Full Text] [Related]
18. Increase in apoptosis and decrease in ornithine decarboxylase activity of the gastric mucosa in patients with atrophic gastritis and gastric ulcer after successful eradication of Helicobacter pylori.
Hirasawa R; Tatsuta M; Iishi H; Yano H; Baba M; Uedo N; Sakai N
Am J Gastroenterol; 1999 Sep; 94(9):2398-402. PubMed ID: 10483998
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor-receptor expression correlates with tumor cell proliferation and prognosis in gastric cancer.
Jonjić N; Kovac K; Krasević M; Valković T; Ernjak N; Sasso F; Melato M
Anticancer Res; 1997; 17(5B):3883-8. PubMed ID: 9427797
[TBL] [Abstract][Full Text] [Related]
20. [Ornithine decarboxylase (ODC) activity in the mucosa of human remnant stomach, and the clinical significance on tumor promotion].
Yasumoto K
Nihon Geka Gakkai Zasshi; 1993 Sep; 94(9):1000-7. PubMed ID: 8246863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
